Y! Health Addiction News - Aromasin Reduced Breast Cancer Risk in Postmenopausal Women

Image via WikipediaAromasin Reduced Breast Cancer Risk in Postmenopausal WomenSATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.
notify.mealways connected...Manage Notification SettingsRelated articlesAromasin (exemestane) Reduces Breast Cancer Risk In